结直肠癌患者化疗后CD4+T细胞表面NK相关受体表达水平动态变化及对预后的预测价值OA
Dynamic change of NK related receptor expression on CD4+T cell surface after chemotherapy and its prognostic value in patients with colorectal cancer
目的:探讨结直肠癌(CRC)患者化疗后CD4+T细胞表面自然杀伤(NK)相关受体表达动态变化及对预后的预测价值.方法:选择2020年2月至2023年3月海南省肿瘤医院收治的251例CRC患者为研究对象,收集患者外周血标本,流式细胞术检测CD4+T细胞表面NK相关受体NKG2D及NKG2A表达,根据患者预后情况分为预后良好组(n=154)和预后不良组(n=97),比较两组患者一般资料及化疗期间CD4+T细胞表面NK相关受体表达,分析不同临床病理特征下CD4+T细胞表面NK相关受体表达与预后的关系;广义线性混合效应模型(GLMMs)分析CD4+T细胞表面NK相关受体表达与预后的关系;非条件Logistic回归和限制性立方样条模型分析CD4+T细胞表面NK相关受体表达与预后结局的关系.Kaplan-Meier生存曲线验证NK相关受体NKG2D及NKG2A对CRC患者生存的影响.结果:多变量方差分析显示,预后良好组治疗后1~6个月的NKG2D高于预后不良组(t=9.260,P<0.001;t=6.490,P<0.001;t=10.594,P<0.001);NKG2A低于预后不良组(t=2.085,P=0.038;t=4.258,P<0.001;t=6.085,P<0.001);肿瘤浸润深度、TNM分期、肿瘤分化程度、淋巴结转移均不能影响CD4+T细胞表面NK相关受体表达与预后的关系(P>0.05);GLMMs分析显示,NKG2A水平越高,NKG2D水平越低,CRC患者预后不良风险性越大(P<0.001).剂量-反应关系显示,NKG2D、NKG2A与CRC患者预后的临界点为74.89%、32.75%,小于临界点时,NKG2D与CRC患者预后不良风险呈正相关,NKG2A与CRC患者预后不良风险呈负相关;大于临界点时,NKG2D与CRC患者预后不良风险呈负相关,NKG2A与CRC患者预后不良风险呈正相关.NKG2D低表达患者6个月生存率为42.60%,NKG2D高表达患者6个月生存率为61.57%;NKG2A低表达患者6个月生存率为56.45%,NKG2A高表达患者6个月生存率为37.36%,两组间差异均具有统计学意义(P<0.05).结论:CRC患者化疗后NKG2A表达增加,NKG2D表达降低,导致CD4+T细胞表面NK相关受体表达失衡抑制细胞杀伤功能,进而增加预后不良风险.
Objective:To investigate dynamic changes of natural killer(NK)-related receptors on surface of CD4+T cells after chemotherapy in patients with colorectal cancer(CRC)and its prognostic value.Methods:A total of 251 CRC patients admitted to Hainan Cancer Hospital from February 2020 to March 2023 were selected as study objects.Peripheral blood samples of patients were collected,and expressions of NK-related receptors NKG2D and NKG2A on surface of CD4+T cells were detected by flow cytometry.According to prognosis,patients were divided into good prognosis group(n=154)and poor prognosis group(n=97).General data of two groups and expression of NK-related receptors on surface of CD4+T cells during chemotherapy were compared,and relationship between expression of NK-related receptors on surface of CD4+T cells and prognosis under different clinicopathological characteristics was analyzed.Generalized linear mixed effects models(GLMMs)was used to analyze relationship between expression of NK-related receptors on surface of CD4+T cells and prognosis.Unconditioned Logistic regression and restricted cubic spline model were used to analyze relationship between expression of NK-related receptors on surface of CD4+T cells and prognosis.Kaplan-Meier survival curve was used to verify effects of NK-related receptors NKG2D and NKG2A on survival of CRC patients.Results:Multivariate analysis of variance showed that NKG2D in good prognosis group was higher than poor prognosis group 1 to 6 months after treatment(t=9.260,P<0.001;t=6.490,P<0.001;t=10.594,P<0.001);NKG2A levels were lower than poor prognosis group(t=2.085,P=0.038;t=4.258,P<0.001;t=6.085,P<0.001);depth of tumor invasion,TNM stage,tumor differentiation degree,lymph node metastasis could not affect relationship between expression of NK-related receptors on CD4+T cells and prognosis(P>0.05).GLMMs analysis showed that the higher the expression of NKG2A,the lower the expression of NKG2D,the greater the risk of poor prognosis in CRC patients(P<0.001).Dose-response relationship showed that critical points of NKG2D and NKG2A and prognosis of CRC patients were 74.89%and 32.75%.When critical point was lower than that,NKG2D was positively correlated with risk of poor prognosis of CRC patients,while NKG2A was negatively correlated with risk of poor prognosis of CRC patients.Above critical point,NKG2D was negatively correlated with risk of poor prognosis in CRC patients,and NKG2A was positively correlated with risk of poor prognosis in CRC patients.Six-month survival rate was 42.60%in patients with low expression of NKG2D and 61.57%in patients with high expression of NKG2D.Six-month survival rate of patients with low expression of NKG2A was 56.45%,and 6-month survival rate of patients with high expression of NKG2A was 37.36%,with statistical difference between two groups(P<0.05).Conclusion:Expression of NKG2A is increased and expression of NKG2D is decreased after chemotherapy in CRC patients,imbalance of expression of NK-related receptors on surface of CD4+T cells inhibits killing function of cells,thus increasing risk of poor prognosis.
程蒙;何宽
海南省肿瘤医院肿瘤内科一,海口 570100东莞市中医院外一科,东莞 523000
医药卫生
结直肠癌CD4+TNKG2DNKG2A预后
Colorectal cancerCD4+TNKG2DNKG2APrognosis
《中国免疫学杂志》 2026 (4)
855-861,7
评论